Modafresh - Now Open to Online Direct Orders - in the UK

Opening chapter

Active ingredient of the medicine

Modafinil

Commercial name covered

Modafresh

Tablet strength levels available

Film coated tablets: 100 mg and 200 mg

Clinically common uses

Narcolepsy: a condition causing sudden sleep attacks, ongoing daytime sleepiness with treated obstructive sleep apnoea, and shift work sleep disorder

Modafresh contains the wakefulness promoting medicine modafinil. It is prescribed to reduce inappropriate daytime sleepiness but does not eliminate the underlying cause. Continue condition specific treatments such as CPAP for obstructive sleep apnoea while taking Modafresh.

This page is an independent information summary and should not replace personalised medical advice. Quick jumps: go to dosing and administration, social a mutual exchange of ideass influence perceptions and decisions., incremental pricing data, or UK law and notes on legality. For everyday practical guidance see tips for ongoing monitoring and practical guidance.

Who is Modafresh intended to help?

Clinicians may offer modafinil to adults in order to improve daytime alertness in the following situations:

• Narcolepsy syndrome, whether or not cataplexy occurs.
• Persistent excessive daytime sleepiness in people with adequately treated obstructive sleep apnoea
• Shift work sleep disorder, to help maintain alertness during working hours

It is an adjunct to, not a replacement for, sufficient sleep, sleep hygiene, or disease specific therapies. Using modafinil for cognitive enhancement in healthy people is not advised and may contravene British legal regulations.

Modafinil action in the brain

Modafinil promotes wakefulness through several brain systems. It affects dopamine and norepinephrine signalling by interacting with transporters and also influences histamine and orexin pathways. Run a comparisond with classic amphetamine type stimulants, typical therapeutic doses are generally less likely to produce intense agitation or jitteriness, although individual responses differ.

Onset of effect is commonly within one to two hours, with activity often lasting across the working day. It will not remedy chronic sleep deprivation; if night time sleep becomes problematica review timing and dose with your prescriber under dosing and administration specifics.

Administration and dosing procedures

Follow the dosing plan agreed developed with input from your prescriber. Typical adult schedules include:

• Narcolepsy as a neurological sleep disorder or OSA related sleepiness: start at 100 mg to 200 mg on waking; many people take 200 mg once each morning.
• Shift work sleep disorder: 200 mg roughly one hour before the work period begins.

Some specialists may advise splitting a 200 mg dose into 100 mg in the morning with 100 mg early afternoon. Daily doses above 200 mg are not common in UK practice and should only be considered by a specialist. You can ingest these tablets with food or on an empty stomach. To reduce the risk of insomnia, avoid late afternoon or evening dosing.

In significant liver impairment dose reductions are frequently needed. Older adults may start at a lower dose. For contraception implications and timing questions see contraception and pregnancy with breastfeeding.

Alerts and precautionary steps

Tell the prescriber about past or current medical problems such as:

• Psychiatric disorders: anxiety, depression, bipolar disorder, psychosis, or history of substance misuse
• Heart or vascular disease: uncontrolled high blood pressure, angina, arrhythmias, previous heart attack, or structural heart conditions
• Impaired liver or kidney function including cirrhosis or reduced renal function
• Pregnancy, suspected pregnancy, or breastfeeding

Modafinil can lower the effectiveness of hormonal contraceptives. Use reliable non hormonal contraception or add barrier methods while on treatment and for at least two months after stopping. Until you know how the medicine affects you, be cautious about driving, operating machinery, or doing safety critical jobs since pressure in the head, dizziness, anxiety or impaired judgement can occur when starting or adjusting treatment.

Potential peripheral effects

Commonly reported detrimental outcomes include:

• Headache discomfort and dizziness, with nervousness or anxiety
• Nausea, stomach discomfort, reduced appetite, or diarrhoea
• Inability to drift off, dry mouth, nasal congestion, or back pain

Changes in appetite may lead to weight variation. Seek immediate medical help if you experience a severe rash, blistering, swelling of face or throat, chest pain, hallucinations, thoughts of self harm, or very high blood pressure.

Suspected adverse outcomes can be reported to the MHRA via the Yellow Card scheme; see Regulatory and legal caveats for the United Kingdom details: see below.

Who must not take Modafresh

• Anyone with a known hypersensitivity to modafinil, armodafinil, or any tablet component, or who has experienced a severe rash with these drugs
• The little crowd and adolescents under 18 years: modafinil is not recommended in this age group

Avoid consuming alcohol while taking modafinil; alcohol can unpredictably alter the drug's effects and increase risk of impaired judgement.

Potential food-clinically relevant drug social interaction considerations

Provide your clinician with a complete list of current prescriptions, over the counter medicines and supplements. Prominent dialogues include:

• CYP2C19 substrates: modafinil may increase exposure to drugs such as diazepam, omeprazole, propranolol, clomipramine, phenytoin and some SSRIs. Monitor and adjust doses if necessary.
• CYP3A4 substrates: effectiveness of medicines metabolised by CYP3A4, including hormonal contraceptives, cyclosporine, tacrolimus and some benzodiazepines, may be reduced. Use extra contraception and monitor therapeutic effects.
• Warfarin and other anticoagulants: modafinil can affect INR; check INR more frequently when starting, stopping or changing dose.
• MAO inhibitors: avoid co administration unless under specialist supervision and metric monitoring.
• Antiepileptic drugs: modafinil can alter plasma concentrations of some antiepileptics; specialist review and supervision and monitoring may be needed.

Combining modafinil with caffeine or other stimulants can increase palpitations, jitteriness and insomnia. Alcohol solution may make effects less predictable. For contraception specific interpersonal engagements in a system describe exchanges between components. see methods of contraception, in pregnancy and during lactation.

Contraception, pregnancy and lactation care

Modafinil induces some liver enzymes and can reduce the effectiveness of hormonal contraceptives (pills, patches, rings, implants and certain IUDs). Choose a reliable non hormonal method such as a copper IUD or add barrier protection during treatment and for at least two months after stopping.

If you are pregnant, think you might be pregnant, or plan to become pregnant, inform your prescriber. Modafinil is usually avoided during pregnancy unless the potential benefit justifies the possible risk. It is not well established how much modafinil passes into breast milk; discuss feeding plans with your clinician to weigh benefits and risks.

Further resources cautions and essential safety careful precautions and potential drug the exchange between people alerts for broader safety measures to contemplate.

Remedies for a i failed to take a dose

If you skip a dose and it is late in the day or could disrupt night sleep, skip the i missed the dose and take the next dose at the usual time. Do not take two doses to make up for one missed. If it is early in the day and you still have a full period of activity ahead, take the i missed the dose when remembered, provided it will not affect sleep.

Excessive dose of medication first aid guidance

Symptoms of having an overdose can include agitation, restlessness, rapid heartbeat, high blood pressure, nausea, tremor, confusion and sleeplessness. Request emergency medical services at once. In the UK call 999 for an emergency or contact NHS 111 for urgent advice. Do not induce vomiting unless advised by a healthcare professional.

Storing and handling

Keep Modafresh in its original packaging at room temperature, away from excessive heat, moisture and direct sunlight. Do not stash this in the bathroom. Keep this product away from children and animals. Do not use after this date expires. Dispose of unused or expired medicines at a pharmacy for safe disposal.

Practical suggestions for the act of monitoring and related areas

• Record benefits and negative health impacts: note sleepiness levels, a mild headaches, anxiety or insomnia and discuss these via your clinician.
• Measure blood pressure and heart rate periodically, particularly if you have cardiovascular risk factors.
• Maintain good sleep hygiene, keep a regular sleep schedule, and optimise adherence to CPAP where relevant.
• Adjust dose timing if night time sleep becomes disturbed; consider taking the dose earlier in the morning rather than later.
• Review fitness to drive and safety critical work regularly; see DVLA guidance in the law a part of the document.

Different options and related other possible paths

Treatment choice depends on diagnosis, presence of cataplexy, comorbiditycapabilities the process of people engagings in a system describe exchanges between components. and patient preference. Secondary options include:

• Solriamfetol (Sunosi): a norepinephrine and dopamine reuptake inhibitor for excessive daytime sleepiness in narcolepsy and OSA; usually once daily.
• Pitolisant (Wakix): an H3 histamine receptor inverse agonist that can improve wakefulness and may help cataplexy in narcolepsy.
• Classical stimulants: dexamfetamine or methylphenidate used under specialist supervision in selected cases.
• Sodium oxybate (Xyrem/Xywav): used for cataplexy and disrupted nocturnal sleep in narcolepsy; specialist initiation and system monitoring are required.
• Armodafinil: the R enantiomer of modafinil; availability and licensing differ by country and it is not routinely supplied in the UK market in all areas.
• Generic forms and other brand names of modafinil (for example Provigil) contain the same active ingredient; some international brands are not licensed for UK pharmacy supply.

Non pharmaceutical measures such as strategic naps, light exposure management for shift work and optimising CPAP are important. See price ranking and comparison study and go through all options with your clinician present.

UK price an executive summary (GBP)

Cost depends on whether you obtain the medicine on the NHS or privately, your exemption status, and any dispensing charges. The following are approximate private cost and pricing model levels and are for guidance only:

• Modafinil 100 mg generic: approximately 1.00 to 2.00 GBP per tablet; a 30 day supply may cost around 30 to 60 GBP plus dispensing fees.
• Modafinil 200 mg generic: roughly 1.50 to 3.00 GBP per tablet; monthly costs commonly fall in the 45 to 90 GBP range depending on dose.
• Brand Provigil (where available): typically more expensive than generics; prices vary by supplier.
• Solriamfetol (Sunosi): often 60 to 120 GBP per month privately, depending on dose.
• Pitolisant (Wakix): frequently several hundred pounds per month, for example 250 to 600 GBP or more.
• Sodium oxybate: high costprospective capacityly thousands of pounds per month; normally supplied via specialist routes rather than standard private purchase.

On the NHS in England most adults pay a fixed charge per prescription item unless exempt or holding a prepayment certificate. In Scotland, Wales and Northern Ireland NHS prescriptions are free for residents. Local formulary and commissioning decisions may affect availability.

United Kingdom notes on compliance with law and regulation

• Prescription status: Modafinil is a prescription only medicine under UK human medicines legislation. Supplying or selling it without a prescription is unlawful.
• Online purchases: use only UK registered pharmaceutical stores. Legitimate distance selling pharmacies are regulated by the General Pharmaceutical Council and listed by the MHRA. Websites should display registration details.
• Import rules: bringing in prescription medicines without a valid UK prescription can lead to seizure by Border Force and may breach medicines regulations.
• Driving and the DVLA: certain sleep disorders and medicines may need to be declared to the Driver and Vehicle Licensing Agency. Never drive if sleepy or impaired; discuss fitness to drive through your clinician.
• Sport and anti doping: modafinil is prohibited in competition by WADA. Athletes should consult UK Anti Doping about therapeutic use exemptions.
• Safety reporting: adverse reactions can be reported to the MHRA via the Yellow Card scheme.
• When travelling: carry medicines in original packaging with a copy of the prescription or a clinician letter. Laws in destination countries can differ even though modafinil is not a controlled drug in the UK.

If you are unsure about the legality or safety of any purchase route, speak with a pharmacist or prescriber. For dosing information return to dosing and delivery.

FAQ

• How fast does Modafresh take effect? Most people notice benefits within one to two hours, with effects often lasting through a typical working day. See how modafinil works.
• Can I drink coffee when I am taking modafinil? Limit caffeine, particularly later in the day, to reduce the risk of palpitations and insomnia. See social the back and forth of communications influence perceptions and decisions..
• Is it possible to quarter a tablet? Many 200 mg tablets are scored and can be halved if your prescriber advises. Do not exceed the prescribed daily dose. See dosing protocol and administration.
• Is intermittent use acceptable? Some patients take modafinil only on work days; follow your clinician's guidance and monitor sleep and daytime functioning. See tips for effective monitoring and logging and practical guidance.